| Literature DB >> 27943002 |
Vlad Laurentiu David1, Muhammed Furkan Ercisli2, Alexandru Florin Rogobete3,4, Eugen S Boia1, Razvan Horhat1, Razvan Nitu1, Mircea M Diaconu1, Laurentiu Pirtea1, Ioana Ciuca1, Delia Horhat1, Florin George Horhat1, Monica Licker1, Sonia Elena Popovici2, Sonia Tanasescu1, Calin Tataru5.
Abstract
Several diagnostic methods for the evaluation and monitoring were used to find out the pro-inflammatory status, as well as incidence of sepsis in critically ill patients. One such recent method is based on investigating the genetic polymorphisms and determining the molecular and genetic links between them, as well as other sepsis-associated pathophysiologies. Identification of genetic polymorphisms in critical patients with sepsis can become a revolutionary method for evaluating and monitoring these patients. Similarly, the complications, as well as the high costs associated with the management of patients with sepsis, can be significantly reduced by early initiation of intensive care.Entities:
Keywords: Biomarkers; Critically ill patients; Genetic polymorphisms; Sepsis; miRNAs
Mesh：
Substances：
Year: 2016 PMID： 27943002 DOI： 10.1007/s10528-016-9785-2
Source DB: PubMed Journal: Biochem Genet ISSN： 0006-2928 Impact factor: 1.890